Dana-Farber Cancer Institute (DFCI) originated in 1947 from the Children's Cancer Research Foundation, which was founded by Sidney Farber. The Foundation was incorporated in 1951 as a non-profit institution in the Commonwealth of Massachusetts, "to operate, conduct, and support an institution for pediatric research in relation to the causes, prevention, and treatment of cancer in children." In 1969, its Articles of Incorporation were amended to include activities for patients of all ages. In July 1974, the name of the Foundation was changed to the Sidney Farber Cancer Institute. In 1982, a change to the present name was made in recognition of long-term support of the Charles A. Dana Foundation.

DFCI has long been a regional center for basic and clinical research, for post-graduate and graduate training, and for the application of advanced diagnostic, treatment, and prevention methods to cancer.  It is known for its long history of contributions to basic cancer cell biology, genetic epidemiology, tumor immunology, and clinical/translational cancer research.  It was first designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center in June 1973.  This designation was renewed most recently in February 1991.  With respect to its research activities, the Dana-Farber Cancer Center has been supported by the NCI for more than three decades.

Anderson, Kenneth C.
Bauer-Wu, Susan M
Benz, Edward J.
Block, Susan Dale
DeCaprio, James
Demetri, George D.
Diller, Lisa 
Dranoff, Glenn
Emmons, Karen M.
Fuchs, Charles S.
Griffin, James D.
Harrington, David P.
Iglehart, James Dirk
Johnson, Bruce E.
Kaelin, William G.
Kantoff, Philip Wayne 
Kufe, Donald W.
Li, Frederick P.
Livingston, David M.
Loda, Massimo 
Look, A. Thomas
Mayer, Robert J.
Nadler, Lee
Orkin, Stuart H.
Posner, Marshall R.
Ritz, Jerome 
Shipp, Margaret A.
Shivdasani, Ramesh
Stiles, Charles D.  
Weeks, Jane C.  
Wucherpfennig, Kai W.

Leah Gibbons
Institutional Coordinator, DFCI
leah_gibbons@dfci.harvard.edu
617.632.4864